Caribou Biosciences | ARS: Annual Report to Security Holders
Caribou Biosciences | DEFA14A: Others
Caribou Biosciences | DEF 14A: Definitive information statements
Caribou Biosciences | 8-K: Current report
Caribou Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Caribou Biosciences | 10-K: Annual report
Caribou Biosciences | 8-K: Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Caribou Biosciences | SC 13G: Statement of acquisition of beneficial ownership by individuals-Steven A. Cohen(5.0%),Point72 Asset Management, L.P.(4.5%), etc.
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer O'Byrne Jason
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer MCCLUNG BARBARA G
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Khan Ruhi Ahmad
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Haurwitz Rachel E.
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Kanner Steven
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Zheng Ran
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Sacks Natalie
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Whiting Nancy
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Richardson-Heron Dara
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Director GUGGENHIME ANDREW
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON DAVID LEE
Caribou Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Braunstein Scott
No Data